日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mining and engineering of ene-reductases from marine sediment metagenome for prochiral ACE inhibitor synthesis

从海洋沉积物宏基因组中挖掘和改造烯还原酶,用于合成前手性ACE抑制剂

Zou, Yating; Zhou, Jinghui; Zeng, Yongyi; Chen, Bishuang; Liu, Lan; Xu, Gang

Preoperative prognostic model combining tumor burden score and tumor markers to predict long-term outcomes following hepatectomy for intrahepatic cholangiocarcinoma: a multi-institutional analysis

结合肿瘤负荷评分和肿瘤标志物的术前预后模型预测肝内胆管癌肝切除术后的长期预后:一项多中心分析

Fu, Jun; Huang, Tingfeng; Lin, Qizhu; Li, Jingdong; Bi, Xinyu; Wang, Jianming; Li, Fuyu; Wang, Jian; Wang, Kui; Lou, Jianying; Cheng, Shi; Zeng, Yongyi

NIR-IIb fluorescence ratiometric imaging of tumor-associated neutrophils for immunotherapy efficacy monitoring and strategy optimization.

利用近红外 IIb 荧光比率成像技术对肿瘤相关中性粒细胞进行免疫治疗效果监测和策略优化。

Li Yang, Lin Jinyan, Zou Jianhua, Zeng Yongyi, Liu Xiaolong

Granzyme B activated near-infrared-II ratiometric fluorescent nanoprobe for early detection of tumor response to immunotherapy.

颗粒酶 B 激活的近红外 II 比率荧光纳米探针用于早期检测肿瘤对免疫疗法的反应

Ding Lei, Zhang Xiaolong, Wang Peiyuan, Ke Jianmei, Zhou Yang, Wu Ming, Wei Zuwu, Cao Yanbing, Li Hongsheng, Chen Geng, Zheng Guangwei, Zeng Yongyi, Hong Maochun, Liu Xiaolong

Two-plex in vivo molecular imaging in the second near-infrared window for immunotherapeutic response.

在第二个近红外窗口进行双重体内分子成像,以研究免疫治疗反应

Sun Yupeng, Li Rui, Cai Yike, Liu Yan, Wang Peiyuan, Wu Ming, Zhang Xiaolong, Liao Naishun, Zhang Cuilin, Zheng Aixian, Xu Haipo, Zeng Rui, Zeng Yongyi, Liu Xiaolong

Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications

更正:阿伐普利尼靶向抑制PDGFRA可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效:临床意义

Zhao, Bixing; Zhou, Yang; Cheng, Niangmei; Zheng, Xiaoyuan; Chen, Geng; Qi, Xin; Zhang, Xiangzhi; Wang, Fei; Zhuang, Qiuyu; Assaraf, Yehuda G; Liu, Xiaolong; Wang, Yingchao; Zeng, Yongyi

Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.

用阿伐替尼靶向抑制 PDGFRA,可显著增强乐伐替尼在体外和体内治疗肝细胞癌的疗效:临床意义

Zhao Bixing, Zhou Yang, Cheng Niangmei, Zheng Xiaoyuan, Chen Geng, Qi Xin, Zhang Xiangzhi, Wang Fei, Zhuang Qiuyu, Assaraf Yehuda G, Liu Xiaolong, Wang Yingchao, Zeng Yongyi

Implantable artificial lymph node enables rapid in vivo neoantigen-specific T-cell generation and expansion for improving antitumor immunity

可植入式人工淋巴结能够快速在体内生成和扩增新抗原特异性T细胞,从而增强抗肿瘤免疫力。

Cai, Zhixiong; Lin, Kongying; Dong, Xiuqing; Li, Zhenli; Chen, Geng; Guo, Luobin; Mou, Pan; Chen, Peizhe; Huang, Junjing; Li, Ling; Liu, Xiaolong; Tang, Ruijing; Zeng, Yongyi

China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)

中国肝癌诊疗指南(2024版)

Zhou, Jian; Sun, Huichuan; Wang, Zheng; Cong, Wenming; Zeng, Mengsu; Zhou, Weiping; Liu, Lianxin; Wen, Tianfu; Kuang, Ming; Zhang, Bixiang; Tao, Kaishan; Han, Guohong; Yan, Zhiping; Wang, Maoqiang; Liu, Ruibao; Guo, Jinhe; Zeng, Zhaochong; Liang, Ping; Ren, Zhenggang; Hou, Jinlin; Zhang, Yanqiao; Liu, Xiufeng; Pan, Hongming; Bi, Feng; Liang, Changhong; Chen, Min; Yan, Fuhua; Xu, Huixiong; Xie, Xiaoyan; Ju, Shenghong; Ji, Yuan; Yun, Jingping; Li, Zengshan; Bai, Xueli; Cai, Dingfang; Chen, Weixia; Chen, Yajin; Chen, Yongjun; Cheng, Wenwu; Cheng, Shuqun; Dai, Zhi; Dai, Chaoliu; Gao, Qiang; Guo, Rongping; Guo, Wengzhi; Guo, Yabing; Hua, Baojin; Huang, Xiaowu; Jiang, Hanyu; Jia, Weidong; Li, Qiu; Li, Tao; Li, Xiangcheng; Li, Xun; Li, Yaming; Li, Yexiong; Liang, Jun; Liang, Xiao; Ling, Changquan; Liu, Hui; Liu, Tianshu; Lu, Shichun; Lv, Guoyue; Mao, Yilei; Meng, Zhiqiang; Peng, Tao; Ren, Weixin; Shi, Guoming; Shi, Hongcheng; Shi, Ming; Song, Tianqiang; Tan, Guang; Wang, Jianhua; Wang, Kui; Wang, Lu; Wang, Wentao; Wang, Xiaoying; Wang, Zhiming; Xiang, Bangde; Xia, Jun; Xing, Baocai; Xu, Jianming; Xu, Jun; Yang, Jianyong; Yang, Xinrong; Yang, Yefa; Yang, Yunke; Yao, Xiaohong; Yin, Zhenyu; Yuan, Zhengang; Zeng, Yongyi; Zeng, Yong; Zhang, Boheng; Zhang, Leida; Zhang, Shuijun; Zhang, Ti; Zhang, Zhiwei; Zhao, Ming; Zhao, Yongfu; Zheng, Honggang; Zhou, Ledu; Zhu, Jiye; Zhu, Kangshun; Shi, Yinghong; Liu, Rong; Zhang, Lan; Xiao, Yongsheng; Yang, Chun; Wu, Zhifeng; Ding, Zhengbin; Zhu, Xiaodong; Tang, Zheng; Huang, Xiaoyong; Han, Hong; Wu, Hong; Chen, Minshan; Wang, Weilin; Li, Qiang; Cai, Jianqiang; Shen, Feng; Cai, Xiujun; Qin, Shukui; Teng, Gaojun; Fan, Jia

Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study

比较乐伐替尼与贝伐单抗联合免疫检查点抑制剂和介入三联疗法治疗中国晚期肝细胞癌的疗效:CLEAP 2302 研究

Pan, Zhaolong; Liu, Dongming; Cao, Junbo; Fu, Linlin; Zhang, Xihao; Zhu, Xiaodong; Pan, Yangxun; Liu, Jianwei; Han, Chuangye; Jin, Renan; Shen, Shunli; Zhang, Xiaoyun; Liu, Hongzhi; Yang, Xiaobo; Hu, Kuan; Shi, Xiaoyi; Wang, Dongxu; Zhao, Yang; Zhong, Jianhong; Xiang, Bangde; Gu, Shanzhi; Li, Tao; Zhang, Shuijun; Zhou, Ledu; Zhao, Haitao; Zeng, Yongyi; Wen, Tianfu; Kuang, Ming; Liang, Xiao; Peng, Tao; Wang, Kui; Xu, Li; Li, Huikai; Song, Tianqiang; Sun, Huichuan; Zhang, Wei